Lansoprazole
NDC 65862-895, Lansoprazole, tablet, orally disintegrating, delayed release, from Aurobindo Pharma Limited.
- Product NDC
- 65862-895
- Status
- Listed
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207167
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65862-895 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LANSOPRAZOLE15 mg/1
Pharmacologic classes
Inhibition Gastric Acid Secretion [PE]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65862-895-78 | 65862089578 | 10 BLISTER PACK in 1 CARTON (65862-895-78) / 10 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK (65862-895-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1f2883d8-12db-40b7-9104-22a6690a22a7NADAC price for package 65862089578
GET /v1/drugs/nadac/65862089578
Use it
Look up 65862-895 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65862-895 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65862-895. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.